Accessibility help Skip to navigation Skip to content Skip to footer

FT Health: Vaccines

Vaccine research grows vigorously, propelled by rising world demand to fight existing diseases and to guard against new threats. Ebola and Zika have recently caused huge international alarm. Yet the Trump era may give voice to increased vaccine scepticism

© Getty

Demands of disease drive vaccine science
Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists
Shandong vaccine scandal damages confidence in China health system
Chinese black market case shines light on poor regulation
Zika vaccine researchers seek to ‘fight fire with fire’
Plans include using one virus to attack another
Amid vaccine debate, Italy faces return of eradicable diseases
Moves to widen vaccination coverage meet strong political opposition
Science looks to nucleic acids to create right genetic vaccine recipe
Proponents say vaccines made of RNA and DNA will prove safer and cheaper
Trump era strengthens the vaccine doubters’ resolve
Medical community worries as a powerful new voice amplifies support for the ‘vaccine hesitant’
Partnership of nations set to combat pandemic health threats
International team of specialists takes fight to emerging lethal infections that as yet have no name
‘Holy grail’ of universal cancer cure remains a distant prospect
Successful trials and wide-ranging approaches continue to stir hopes of new means of tackling the disease